Decitabine improves platelet recovery by down-regulating IL-8 level in MDS/AML patients with thrombocytopenia

Blood Cells Mol Dis. 2019 May:76:66-71. doi: 10.1016/j.bcmd.2019.02.003. Epub 2019 Feb 20.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Blood Platelets / drug effects*
  • Decitabine / pharmacology*
  • Decitabine / therapeutic use
  • Down-Regulation
  • Female
  • Humans
  • Interleukin-8 / drug effects*
  • Leukemia, Myeloid, Acute / complications
  • Leukemia, Myeloid, Acute / drug therapy*
  • Middle Aged
  • Myelodysplastic Syndromes / complications
  • Myelodysplastic Syndromes / drug therapy*
  • Thrombocytopenia*
  • Treatment Outcome

Substances

  • Interleukin-8
  • Decitabine